PBM Reform Act of 2025

Legislative bill overview

HR 4317, titled aims to protect and enhance the ability of Medicare beneficiaries to access a broad range of pharmacies. The bill addresses restrictions imposed by Medicare Part D plans that may limit beneficiary choice or access to pharmacies, including potential prohibitions or restrictions on the use of certain pharmacies. The goal is to ensure that Medicare recipients maintain the freedom to choose their pharmacy, promoting competition and access to affordable medications.

Why is this important

Access to pharmacies is critical for Medicare beneficiaries, many of whom rely on consistent, affordable, and convenient medication access for chronic conditions. Limiting pharmacy options can reduce competition, potentially driving up costs and reducing service quality. By safeguarding beneficiary choice, the bill seeks to enhance patient-centered care, reduce barriers to medication adherence, and foster competitive pricing among pharmacies, ultimately supporting better health outcomes for an aging population.

Potential points of contention

• Some Medicare Part D plans may argue that restrictions on limiting pharmacies limit their ability to negotiate better prices or implement preferred pharmacy networks, potentially increasing plan costs.
• Pharmacy benefit managers (PBMs) may see this as a challenge to their business model that relies on steering patients towards certain pharmacies.
• Opponents could argue that maintaining broad pharmacy choice could lead to higher overall Medicare costs if plans cannot manage pharmacy networks for cost-effectiveness.
• The bill may face scrutiny over enforcement mechanisms and whether they will impose new administrative burdens on plans or pharmacies.